FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

VIJAYA DIAGNOSTIC CENTRE LTD.

NSE : VIJAYABSE : 543350ISIN CODE : INE043W01024Industry : Hospital & Healthcare ServicesHouse : Private

BSE996.205.9 (+0.6 %)

PREV CLOSE (Rs.) 990.30

OPEN PRICE (Rs.) 989.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2165

TODAY'S LOW / HIGH (Rs.)987.05 1004.00

52 WK LOW / HIGH (Rs.)800 1191.05

NSE996.305 (+0.5 %)

PREV CLOSE( Rs. ) 991.30

OPEN PRICE (Rs.) 988.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 44506

TODAY'S LOW / HIGH(Rs.) 985.70 1004.20

52 WK LOW / HIGH (Rs.)740 1192

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

21.60

Dividend Yield(%)

0.20

TTM EPS (Rs.)

15.28

P/E Ratio

65.20

Book Value (Rs.)

87.39

Face Value (Rs.)

MCap (Rs. in Mn)

96327.07

Price/Earning (TTM)

43.90

Price/Sales (TTM)

14.16

Price/Book (MRQ)

11.40

PAT Margin (%)

21.53

ROCE (%)

28.71

Incorporation Year : 05-06 2002

Management Info :

Sura Surendranath Reddy - Chairman Sura S Reddy - Managing Director

Registered Office :

Address : 6-3-883/ F , F P A Building,Near Topaz Building,Punjagutta,
Hyderabad,
Telangana-500082

Phone : 040 2342 0411-12

Email : info@vijayadiagnostic.com

Website : www.vijayadiagnostic.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

02Jan Vijaya Diagnostic Centre informs about
Vijaya Diagnostic Centre has informed that it enclosed Compliance Certif..

05Dec Clarification sought from Vijaya Diag
The Exchange has sought clarification from Vijaya Diagnostic Centre Ltd..

05Nov Vijaya Diagnostic Centre informs about
Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligat..

Financials

	QTR Sep 25	ANNUAL 25
Net Profit	427	1350.12
Gross Profit	570.52	1813.02
Operating Profit	836.61	2718.1
Net Sales	1893.53	6271.38

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Nephrocare Health Se (BSE)

509.15 (2.57%)

M.Cap (Rs. in Cr)5108.85

RainbowChildrenS Med (BSE)

1185.85 (0.71%)

M.Cap (Rs. in Cr)12043.39

Lotus Eye Hospital (BSE)

121.95 (4.99%)

M.Cap (Rs. in Cr)253.61

Krsnaa Diagnostics (BSE)

715.10 (0.74%)

M.Cap (Rs. in Cr)2319.69

Shareholding Pattern

	PROMOTERS	52.6%
	MUTUAL FUNDS/UTI	27.98%
	NON-INSTITUTION	3.71%
	FI/BANKS/INSURANCE	0.51%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Nippon India Pharma...

3.32

DSP Healthcare Fund...

3.02

Kotak Small Cap Fund(G)

2.61

Kotak Business Cycl...

2.44

HDFC Pharma and Hea...

2.35

Motilal Oswal Small...

2.11

Bank of India Small...

1.89

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

VIJAYA DIAGNOSTIC CENTRE LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives